HomeIOVA • NASDAQ
add
Iovance Biotherapeutics Inc
$3.51
Makalipas ang Oras ng Trabaho:(0.57%)+0.020
$3.53
Sarado: Abr 25, 7:50:24 PM GMT-4 · USD · NASDAQ · Disclaimer
Nakaraang pagsara
$3.36
Sakop ng araw
$3.25 - $3.64
Sakop ng taon
$2.70 - $14.23
Market cap
1.15B USD
Average na Volume
9.25M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Mga balita tungkol sa merkado
Investor's Business Daily
1 oras ang nakalipas
What To Do Amid Tariffs, Earnings? Listen To The Market
0.050%
2.65%
0.44%
1.31%
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 73.69M | 15,189.21% |
Gastos sa pagpapatakbo | 114.73M | -2.25% |
Net na kita | -78.56M | 32.50% |
Net profit margin | -106.60 | 99.56% |
Kita sa bawat share | -0.26 | 42.22% |
EBITDA | -78.06M | 31.77% |
Aktuwal na % ng binabayarang buwis | -2.02% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 323.78M | 15.69% |
Kabuuang asset | 910.43M | 16.67% |
Kabuuang sagutin | 200.02M | 2.19% |
Kabuuang equity | 710.40M | — |
Natitirang share | 327.88M | — |
Presyo para makapag-book | 1.44 | — |
Return on assets | -22.76% | — |
Return on capital | -26.70% | — |
Cash Flow
Net change in cash
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -78.56M | 32.50% |
Cash mula sa mga operasyon | -73.30M | 12.71% |
Cash mula sa pag-invest | 23.68M | 132.50% |
Cash mula sa financing | 2.31M | 140.02% |
Net change in cash | -48.49M | 68.27% |
Malayang cash flow | -44.82M | -12.25% |
Tungkol
Iovance Biotherapeutics, Inc. is a biopharmaceutical startup based in San Carlos, California. The company works to develop tumor-infiltrating lymphocyte therapies against cancer. Wikipedia
Itinatag
2007
Headquarters
Website
Mga Empleyado
838
